ID   KPCZ_HUMAN              Reviewed;         592 AA.
AC   Q05513; A8K4N0; Q15207; Q5SYT5; Q969S4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 4.
DT   05-OCT-2010, entry version 128.
DE   RecName: Full=Protein kinase C zeta type;
DE            EC=2.7.11.13;
DE   AltName: Full=nPKC-zeta;
GN   Name=PRKCZ; Synonyms=PKC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Frontal cortex;
RX   MEDLINE=94040779; PubMed=8224878; DOI=10.1016/0378-1119(93)90213-M;
RA   Barbee J.L., Loomis C.R., Deutscher S.L., Burns D.J.;
RT   "The cDNA sequence encoding human protein kinase C-zeta.";
RL   Gene 132:305-306(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-592.
RC   TISSUE=Hippocampus;
RX   MEDLINE=93387312; PubMed=8375396;
RX   DOI=10.1111/j.1432-1033.1993.tb18179.x;
RA   Kochs G., Hummel R., Meyer D., Hug H., Marme D., Sarre T.F.;
RT   "Activation and substrate specificity of the human protein kinase C
RT   alpha and zeta isoenzymes.";
RL   Eur. J. Biochem. 216:597-606(1993).
RN   [7]
RP   INTERACTION WITH SQSTM1, AND SUBCELLULAR LOCATION.
RX   PubMed=9566925;
RA   Sanchez P., De Carcer G., Sandoval I.V., Moscat J., Diaz-Meco M.T.;
RT   "Localization of atypical protein kinase C isoforms into lysosome-
RT   targeted endosomes through interaction with p62.";
RL   Mol. Cell. Biol. 18:3069-3080(1998).
RN   [8]
RP   PHOSPHORYLATION AT THR-410 BY PDPK1.
RX   PubMed=9768361; DOI=10.1016/S0960-9822(98)70444-0;
RA   Chou M.M., Hou W., Johnson J., Graham L.K., Lee M.H., Chen C.S.,
RA   Newton A.C., Schaffhausen B.S., Toker A.;
RT   "Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.";
RL   Curr. Biol. 8:1069-1077(1998).
RN   [9]
RP   INTERACTION WITH SQSTM1 AND IKBKB.
RX   PubMed=10356400; DOI=10.1093/emboj/18.11.3044;
RA   Sanz L., Sanchez P., Lallena M.-J., Diaz-Meco M.T., Moscat J.;
RT   "The interaction of p62 with RIP links the atypical PKCs to NF-kappaB
RT   activation.";
RL   EMBO J. 18:3044-3053(1999).
RN   [10]
RP   INTERACTION WITH PARD6A; PARD6B AND PARD6G.
RC   TISSUE=Neuroblastoma;
RX   MEDLINE=21160560; PubMed=11260256;
RX   DOI=10.1046/j.1365-2443.2001.00404.x;
RA   Noda Y., Takeya R., Ohno S., Naito S., Ito T., Sumimoto H.;
RT   "Human homologues of the Caenorhabditis elegans cell polarity protein
RT   PAR6 as an adaptor that links the small GTPases Rac and Cdc42 to
RT   atypical protein kinase C.";
RL   Genes Cells 6:107-119(2001).
RN   [11]
RP   INTERACTION WITH SQSTM1 AND PAWR.
RX   MEDLINE=21629081; PubMed=11755531; DOI=10.1016/S0014-5793(01)03224-0;
RA   Chang S., Kim J.H., Shin J.;
RT   "p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes
RT   PAR-4-induced PKCzeta inhibition.";
RL   FEBS Lett. 510:57-61(2002).
RN   [12]
RP   INTERACTION WITH PARD3.
RX   MEDLINE=22220120; PubMed=12234671; DOI=10.1016/S0378-1119(02)00681-9;
RA   Gao L., Macara I.G., Joberty G.;
RT   "Multiple splice variants of Par3 and of a novel related gene, Par3L,
RT   produce proteins with different binding properties.";
RL   Gene 294:99-107(2002).
RN   [13]
RP   INTERACTION WITH ADAP1.
RX   MEDLINE=22774667; PubMed=12893243; DOI=10.1016/S0006-291X(03)01187-2;
RA   Zemlickova E., Dubois T., Kerai P., Clokie S., Cronshaw A.D.,
RA   Wakefield R.I.D., Johannes F.-J., Aitken A.;
RT   "Centaurin-alpha(1) associates with and is phosphorylated by isoforms
RT   of protein kinase C.";
RL   Biochem. Biophys. Res. Commun. 307:459-465(2003).
RN   [14]
RP   INTERACTION WITH SQSTM1 AND PARD6B, DOMAIN, AND MUTAGENESIS OF LYS-19;
RP   ASP-62 AND ASP-66.
RX   MEDLINE=22770673; PubMed=12887891; DOI=10.1016/S1097-2765(03)00246-6;
RA   Wilson M.I., Gill D.J., Perisic O., Quinn M.T., Williams R.L.;
RT   "PB1 domain-mediated heterodimerization in NADPH oxidase and signaling
RT   complexes of atypical protein kinase C with Par6 and p62.";
RL   Mol. Cell 12:39-50(2003).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   INTERACTION WITH WWC1 AND DDR1.
RX   PubMed=18190796; DOI=10.1016/j.bbamcr.2007.12.007;
RA   Hilton H.N., Stanford P.M., Harris J., Oakes S.R., Kaplan W.,
RA   Daly R.J., Ormandy C.J.;
RT   "KIBRA interacts with discoidin domain receptor 1 to modulate
RT   collagen-induced signalling.";
RL   Biochim. Biophys. Acta 1783:383-393(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-410, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-560, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-514.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-84 AND CYS-519.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This is a calcium-independent, phospholipid-dependent,
CC       serine- and threonine-specific enzyme.
CC   -!- FUNCTION: PKC is activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. PKC also serves as
CC       the receptor for phorbol esters, a class of tumor promoters.
CC       Subunit of a quaternary complex that plays a central role in
CC       epithelial cell polarization.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Phosphatidylinositol 3,4,5-trisphosphate might
CC       be a physiological activator. Two specific sites, Thr-410
CC       (activation loop of the kinase domain) and Thr-560 (turn motif),
CC       need to be phosphorylated for its full activation.
CC   -!- SUBUNIT: Forms a ternary complex with SQSTM1 and KCNAB2. Forms
CC       another ternary complex with SQSTM1 and GABRR3. Forms a complex
CC       with SQSTM1 and MAP2K5 (By similarity). Interacts with PARD6A,
CC       PARD6B, PARD6G and SQSTM1. Part of a complex with PARD3, PARD6A or
CC       PARD6B or PARD6G and CDC42 or RAC1. Interacts with ADAP1/CENTA1.
CC       Forms a ternary complex composed of SQSTM1 and PAWR. Interacts
CC       directly with SQSTM1 (Probable). Interacts with IKBKB. Interacts
CC       (via the protein kinase domain) with WWC1. Forms a tripartite
CC       complex with WWC1 and DDR1, but predominantly in the absence of
CC       collagen.
CC   -!- INTERACTION:
CC       Q9BYG5:PARD6B; NbExp=1; IntAct=EBI-295351, EBI-295391;
CC       Q04759:PRKCQ; NbExp=2; IntAct=EBI-295351, EBI-374762;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Endosome. Note=In the retina,
CC       localizes in the terminals of the rod bipolar cells (By
CC       similarity). Associates with endosomes.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, and to a lesser extent in
CC       lung, kidney and testis.
CC   -!- DOMAIN: The OPR domain mediates mutually exclusive interactions
CC       with SQSTM1 and PARD6B.
CC   -!- DOMAIN: The C1 domain does not bind the diacylglycerol (DAG).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 OPR domain.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA78813.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L14283; AAA36488.1; -; mRNA.
DR   EMBL; BT007082; AAP35745.1; -; mRNA.
DR   EMBL; AK290995; BAF83684.1; -; mRNA.
DR   EMBL; AL391845; CAI15438.1; -; Genomic_DNA.
DR   EMBL; AL590822; CAI15438.1; JOINED; Genomic_DNA.
DR   EMBL; AL645703; CAI15438.1; JOINED; Genomic_DNA.
DR   EMBL; AL645703; CAI21535.1; -; Genomic_DNA.
DR   EMBL; AL391845; CAI21535.1; JOINED; Genomic_DNA.
DR   EMBL; AL590822; CAI21535.1; JOINED; Genomic_DNA.
DR   EMBL; BC008058; AAH08058.1; -; mRNA.
DR   EMBL; BC014270; AAH14270.1; -; mRNA.
DR   EMBL; Z15108; CAA78813.1; ALT_INIT; mRNA.
DR   IPI; IPI00013749; -.
DR   PIR; JN0877; JN0877.
DR   RefSeq; NP_001028753.1; -.
DR   RefSeq; NP_001028754.1; -.
DR   RefSeq; NP_002735.3; -.
DR   UniGene; Hs.496255; -.
DR   ProteinModelPortal; Q05513; -.
DR   SMR; Q05513; 12-98, 109-181, 247-584.
DR   IntAct; Q05513; 13.
DR   MINT; MINT-5004464; -.
DR   STRING; Q05513; -.
DR   PhosphoSite; Q05513; -.
DR   PRIDE; Q05513; -.
DR   Ensembl; ENST00000378567; ENSP00000367830; ENSG00000067606.
DR   GeneID; 5590; -.
DR   KEGG; hsa:5590; -.
DR   UCSC; uc001aiq.1; human.
DR   CTD; 5590; -.
DR   GeneCards; GC01P001939; -.
DR   H-InvDB; HIX0000046; -.
DR   H-InvDB; HIX0029201; -.
DR   HGNC; HGNC:9412; PRKCZ.
DR   HPA; CAB004533; -.
DR   HPA; HPA021851; -.
DR   MIM; 176982; gene.
DR   PharmGKB; PA33775; -.
DR   eggNOG; prNOG08632; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q05513; -.
DR   OMA; AYISSTR; -.
DR   OrthoDB; EOG93N9ZG; -.
DR   PhylomeDB; Q05513; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; il2_pi3kpathway; IL2 signaling events mediated by PI3K.
DR   Pathway_Interaction_DB; insulin_pathway; Insulin Pathway.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; trkrpathway; Neurotrophic factor-mediated Trk receptor signaling.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   Reactome; REACT_604; Hemostasis.
DR   BindingDB; Q05513; -.
DR   NextBio; 21684; -.
DR   PMAP-CutDB; Q05513; -.
DR   ArrayExpress; Q05513; -.
DR   Bgee; Q05513; -.
DR   CleanEx; HS_PRKCZ; -.
DR   Genevestigator; Q05513; -.
DR   GermOnline; ENSG00000067606; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IC:BHF-UCL.
DR   GO; GO:0004697; F:protein kinase C activity; IEA:EC.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006916; P:anti-apoptosis; TAS:ProtInc.
DR   GO; GO:0046627; P:negative regulation of insulin receptor sig...; IMP:BHF-UCL.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine ph...; IMP:BHF-UCL.
DR   GO; GO:0031333; P:negative regulation of protein complex asse...; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000270; OPR_PB1.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR012233; PKC_zeta.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000554; PKC_zeta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Endosome; Kinase;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    592       Protein kinase C zeta type.
FT                                /FTId=PRO_0000055701.
FT   DOMAIN       15     98       OPR.
FT   DOMAIN      252    518       Protein kinase.
FT   DOMAIN      519    590       AGC-kinase C-terminal.
FT   ZN_FING     130    180       Phorbol-ester/DAG-type.
FT   NP_BIND     258    266       ATP (By similarity).
FT   REGION       79    145       Interaction with SQSTM1 (By similarity).
FT   ACT_SITE    376    376       Proton acceptor (By similarity).
FT   BINDING     281    281       ATP (By similarity).
FT   MOD_RES     223    223       Phosphoserine.
FT   MOD_RES     410    410       Phosphothreonine; by PDPK1.
FT   MOD_RES     560    560       Phosphothreonine.
FT   VARIANT      49     49       R -> H (in dbSNP:rs35271800).
FT                                /FTId=VAR_050560.
FT   VARIANT      84     84       R -> H (in dbSNP:rs56017162).
FT                                /FTId=VAR_042310.
FT   VARIANT     514    514       S -> F (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035467.
FT   VARIANT     519    519       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042311.
FT   MUTAGEN      19     19       K->A: No effect on interaction with
FT                                SQSTM1 and PARD6B.
FT   MUTAGEN      62     62       D->A: Loss of interaction with SQSTM1 and
FT                                PARD6B.
FT   MUTAGEN      66     66       D->A: Loss of interaction with SQSTM1 and
FT                                PARD6B.
FT   CONFLICT      6      6       G -> D (in Ref. 1; AAA36488).
FT   CONFLICT    198    198       K -> R (in Ref. 3; BAF83684).
FT   CONFLICT    262    262       S -> T (in Ref. 1; AAA36488).
FT   CONFLICT    366    366       F -> L (in Ref. 3; BAF83684).
FT   CONFLICT    500    500       R -> G (in Ref. 3; BAF83684).
FT   CONFLICT    522    522       D -> G (in Ref. 3; BAF83684).
SQ   SEQUENCE   592 AA;  67660 MW;  88CCD0577E6A596C CRC64;
     MPSRTGPKME GSGGRVRLKA HYGGDIFITS VDAATTFEEL CEEVRDMCRL HQQHPLTLKW
     VDSEGDPCTV SSQMELEEAF RLARQCRDEG LIIHVFPSTP EQPGLPCPGE DKSIYRRGAR
     RWRKLYRANG HLFQAKRFNR RAYCGQCSER IWGLARQGYR CINCKLLVHK RCHGLVPLTC
     RKHMDSVMPS QEPPVDDKNE DADLPSEETD GIAYISSSRK HDSIKDDSED LKPVIDGMDG
     IKISQGLGLQ DFDLIRVIGR GSYAKVLLVR LKKNDQIYAM KVVKKELVHD DEDIDWVQTE
     KHVFEQASSN PFLVGLHSCF QTTSRLFLVI EYVNGGDLMF HMQRQRKLPE EHARFYAAEI
     CIALNFLHER GIIYRDLKLD NVLLDADGHI KLTDYGMCKE GLGPGDTTST FCGTPNYIAP
     EILRGEEYGF SVDWWALGVL MFEMMAGRSP FDIITDNPDM NTEDYLFQVI LEKPIRIPRF
     LSVKASHVLK GFLNKDPKER LGCRPQTGFS DIKSHAFFRS IDWDLLEKKQ ALPPFQPQIT
     DDYGLDNFDT QFTSEPVQLT PDDEDAIKRI DQSEFEGFEY INPLLLSTEE SV
//
